SS Innovations International, Inc.
Business
SS Innovations International, Inc. designs, manufactures, and markets the SSi Mantra, an advanced surgical robotic system for minimally invasive procedures across multiple specialties including general, urological, gynecological, cardiac, and colorectal surgery. The company offers its systems through direct sales in India and an expanding distributor network across 10+ countries, with 168 installed systems as of December 31, 2025. Revenue derives from system sales via outright purchase, deferred payment, and pay-per-procedure models, plus recurring consumables including instruments, accessories, and services. The company is pursuing FDA and EU regulatory clearance for entry into developed markets.
Summary from 10-K filed 2026-03-10
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Total revenue | 42 | 21 | — | — | — | |
| Cost of revenue | −23 | −12 | −5 | −968,721 | — | |
| GROSS PROFIT | 20 | 8 | 725,528 | 489,594 | — | |
| Research & development expense | 4 | 2 | 1 | 83,282 | 1,000 | |
| Stock compensation expense | 8 | 14 | 10 | — | — | |
| Depreciation and amortization expense | 1 | 436,005 | 152,738 | — | — | |
| Selling, general and administrative expense | 15 | 10 | 10 | 3 | — | |
| TOTAL OPERATING EXPENSES | 28 | 27 | 21 | 6 | 1 | |
| Loss from operations | −8 | −19 | −20 | −6 | — | |
| Interest Expense | −1 | −973,235 | −894,621 | — | — | |
| Interest and other income, net | 1 | 798,000 | 290,313 | — | — | |
| TOTAL INCOME / (EXPENSE), NET | 33,087 | −175,235 | −604,308 | 77,729 | −77,274 | |
| LOSS BEFORE INCOME TAXES | −8 | −19 | −21 | −2 | −1 | |
| Income tax expense | 4 | — | — | — | — | |
| NET LOSS | −12 | −19 | −21 | −6 | −1 | |
| Net loss per share - basic (in Dollars per share) | −0.06 | −0.11 | −0.14 | −0.14 | −0.05 | |
| Net loss per share - diluted (in Dollars per share) | −0.06 | −0.11 | −0.14 | −0.14 | −0.05 | |
| Weighted average- basic shares (in Shares) | 190 | 171 | 145 | 41 | 28 | |
| Weighted average- diluted shares (in Shares) | 199 | 181 | 152 | 41 | 28 | |
| Foreign currency translation loss | −1 | −539,900 | −243,089 | 15,521 | — | |
| Retirement Benefit | −68,809 | −14,226 | −7,009 | — | — | |
| Retirement Benefit | 1,433 | — | — | — | — | |
| Income tax effects relating to retirement benefit | 20,037 | — | — | — | — | |
| TOTAL OTHER COMPREHENSIVE LOSS | −1 | −554,126 | — | — | — | |
| TOTAL COMPREHENSIVE LOSS | −13 | −20 | −21 | −6 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 3 | 466,500 | 2 | 2 | 405,774 | |
| Restricted cash | 6 | 6 | 5 | 63,492 | — | |
| Accounts receivable, net | 12 | 4 | 2 | 592,313 | — | |
| Inventory, net | 17 | 10 | 7 | 855,777 | — | |
| Prepaids and other current assets | 10 | 6 | 5 | 700,920 | — | |
| Total Current Assets | 49 | 27 | 21 | 7 | 408,065 | |
| Property, plant, and equipment, net | 9 | 5 | 706,405 | 388,820 | 20,542 | |
| Right of use asset | 3 | 3 | 3 | — | — | |
| Deferred tax assets, net | 533,727 | — | — | — | — | |
| Accounts receivable, net | 9 | 3 | 2 | — | — | |
| Restricted cash | 458,964 | 318,527 | 35,919 | — | — | |
| Prepaids and other non current assets | 4 | 3 | 4 | — | — | |
| Total Assets | 74 | 42 | 32 | 9 | 428,607 | |
| Bank overdraft facility | 11 | 8 | 6 | 3 | — | |
| Notes payable | — | 7 | — | — | — | |
| Current portion of operating lease liabilities | 579,169 | 409,518 | 396,784 | — | — | |
| Accounts payable | 5 | 2 | 901,552 | 618,852 | 124,581 | |
| Deferred revenue | 3 | 1 | 156,330 | — | — | |
| Accrued expenses & other current liabilities | 6 | 2 | 489,939 | 253,377 | — | |
| Total Current Liabilities | 26 | 21 | 8 | 11 | 287,281 | |
| Operating lease liabilities, less current portion | 2 | 2 | 2 | — | — | |
| Deferred Revenue | 7 | 5 | 939,150 | — | — | |
| Other non current liabilities | 288,764 | 74,817 | 33,933 | — | — | |
| Total Liabilities | 36 | 29 | 12 | 11 | — | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock, authorized 5,000,000 shares of Series A, Non-Convertible Preferred Stock, $0.0001 par value per share; 1,000 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | 1 | 1 | 1 | — | — | |
| Common stock, 250,000,000 shares authorized, $0.0001 par value, 194,165,141 shares and 171,579,284 shares issued and outstanding as of December 31, 2025 and December 31, 2024 respectively | 19,416 | 17,157 | 17,072 | 5,389 | 3,785 | |
| Accumulated other comprehensive income (loss) | −2 | −749,625 | −195,499 | 899,917 | — | |
| Additional paid in capital | 95 | 57 | 43 | 11 | 8 | |
| Capital reserve | 899,917 | 899,917 | 899,917 | — | — | |
| Accumulated deficit | −56 | −44 | −25 | −14 | −8 | |
| Total stockholders equity | 38 | 13 | 20 | −3 | −166,380 | |
| Total liabilities and stockholders equity | 74 | 42 | 32 | 9 | 428,607 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Operating lease expense | 827,521 | 753,449 | 560,668 | — | — | |
| Interest Expense | 271,633 | 317,234 | — | — | — | |
| Interest and other income, net | −625,883 | −418,426 | −290,313 | — | — | |
| Property, plant and equipment written off | — | 48,456 | 9,250 | — | — | |
| Provision for credit loss reserve, net | 324,345 | 955,762 | — | — | — | |
| Deferred income tax benefit | −512,865 | — | — | — | — | |
| Provision for slow moving inventory | −110,332 | — | — | — | — | |
| Accounts receivable, net | −13 | −5 | −3 | — | — | |
| Inventory, net | −8 | −8 | −6 | — | — | |
| Deferred revenue | 4 | 5 | 1 | — | — | |
| Prepaids and other assets | −5 | −1 | −3 | −1 | — | |
| Accounts payable | 3 | 1 | 736,075 | — | — | |
| Income taxes payable, net | 4 | — | — | — | — | |
| Accrued expenses & other liabilities | 161,914 | 1 | — | — | — | |
| Operating lease payment | −792,166 | −705,868 | −524,766 | — | — | |
| Net cash used in operating activities | −19 | −10 | −15 | −6 | −363,034 | |
| Purchase of property, plant and equipment | −4 | −661,479 | −453,327 | −220,324 | — | |
| Net cash used in investing activities | −4 | −661,479 | −453,327 | −3 | 38,150 | |
| Proceeds from bank overdraft facility (net) | 3 | 2 | 2 | 3 | — | |
| Proceeds from issuance of promissory notes to principal shareholder | — | 3 | — | 3 | — | |
| Proceeds from issuance of convertible notes to principal shareholder | 28 | 3 | 17 | 4 | — | |
| Proceeds from issuance of convertible notes to other investors | — | 1 | 3 | — | — | |
| Repayment of convertible notes to principal shareholder, including interest | −4 | — | — | — | — | |
| Repayment of convertible notes to other investors, including interest | −1 | — | −126,505 | — | — | |
| Net cash provided by financing activities | 26 | 9 | 23 | 9 | 569,949 | |
| Net change in cash | 4 | −738,529 | 7 | 1 | 245,065 | |
| Effect of exchange rate on cash | −985,026 | 274,219 | −168,094 | 69,189 | — | |
| Conversion of convertible notes into common stock, including interest | 31 | — | — | — | — | |
| Transfer of systems from inventory to property, plant and equipment | 2 | 5 | — | — | — | |
| Transfer of systems from property, plant and equipment to inventory | 1 | — | — | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is SS Innovations International, Inc.'s CIK number?
SS Innovations International, Inc.'s SEC CIK number is 0001676163 (1676163). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find SS Innovations International, Inc.'s SEC filings?
All of SS Innovations International, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did SS Innovations International, Inc. last report earnings?
SS Innovations International, Inc. (SSII) most recently filed an earnings 8-K with the SEC on May 13, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001213900-26-055468). This is SS Innovations International, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is SS Innovations International, Inc.'s most recent earnings 8-K?
SS Innovations International, Inc.'s latest earnings 8-K (Item 2.02) was filed May 13, 2026 under accession 0001213900-26-055468. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View SS Innovations International, Inc.'s latest earnings 8-K →
Look up any company's CIK number →